Dr. Jhanelle E. Gray, M.D.
Claim this profileMoffitt Cancer Center
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
18 reported clinical trials
30 drugs studied
About Jhanelle E. Gray, M.D.
Education:
- Graduated with Honors, B.S., University of Florida (1993–1997).
- Earned M.D., Cornell University Medical College (1997–2001).
Experience:
- Completed Medicine Internship and Residency, The New York Presbyterian Hospital - Cornell (2001–2004).
- Hematology/Medical Oncology Fellowship, Moffitt Cancer Center (2010–2011).
- Serves as Clinical Instructor and Mentor at Moffitt Cancer Center and University of South Florida (2007–present).
- Holds positions as Department Chair, Program Leader, and Senior Member for Thoracic Oncology at Moffitt Cancer Center.
- Appointed Co-Leader of the Molecular Medicine Program at Moffitt Cancer Center.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Jhanelle E. Gray, M.D. is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Jhanelle E. Gray, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Jhanelle E. Gray, M.D. has experience with
- Pembrolizumab
- Pemetrexed
- Carboplatin
- Nivolumab
- Ipilimumab
- Paclitaxel
Breakdown of trials Jhanelle E. Gray, M.D. has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jhanelle E. Gray, M.D. specialize in?
Jhanelle E. Gray, M.D. focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jhanelle E. Gray, M.D. currently recruiting for clinical trials?
Yes, Jhanelle E. Gray, M.D. is currently recruiting for 7 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Jhanelle E. Gray, M.D. has studied deeply?
Yes, Jhanelle E. Gray, M.D. has studied treatments such as Pembrolizumab, Pemetrexed, Carboplatin.
What is the best way to schedule an appointment with Jhanelle E. Gray, M.D.?
Apply for one of the trials that Jhanelle E. Gray, M.D. is conducting.
What is the office address of Jhanelle E. Gray, M.D.?
The office of Jhanelle E. Gray, M.D. is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.